You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

40 Results
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
letrozole
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2020
Regimen
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    lanreotide
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lanreotide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2024
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB Limited Use
    lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
lenalidomide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2022
Cancer facts
Jan 2016
Cancer facts
Nov 2021
Drug
Other Name(s): CeeNU®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2024
Drug
Other Name(s): Vyxeos®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2023
Drug
Other Name(s): Lorbrena®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Feb 2025
Drug
Other Name(s): Somatuline® Autogel®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2024
Drug
Other Name(s): Lederle Leucovorin® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Apr 2019
Drug
Other Name(s): Femara®
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2022
Drug
Other Name(s): Revlimid®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2024

Pages